QIAGEN N.V.

QGEN
Delayed Nyse - 04:00 2022-12-02 pm EST
50.35 USD -0.22%

Turn to zoom
Prev.50.35000000
Open49.98000000
High50.50000000
Low49.73000000
Volume465 317
Latest news
3d ago
11/21
11/21
11/18
Chart QIAGEN N.V.
Technical analysis trends
Short TermMid-TermLong Term
TrendBullishBullishNeutral
Resistance50,550,555,6
Spread/Res.-0,22%-0,22%-9,4%
Spread/Supp.8,1%12%22%
Support46,644,841,3
Financials
Sales 2022 2 153 M - -
Net income 2022 430 M - -
Net Debt 2022 594 M - -
P/E ratio 2022 27,4x
Yield 2022 -
Capitalization 11 465 M 11 465 M -
EV / Sales 2022 5,60x
EV / Sales 2023 5,63x
Nbr of Employees 6 200
Free-Float 98,3%
Company
Qiagen N.V. is one of the world's leaders in designing, manufacturing, and marketing chemical products for the isolation, purification, and manipulation of DNA (deoxyribonucleic acid) and RNA (ribonucleic acid).
In 2021, the group developed more than 500 core consumable products and automated...
Sector :
Other Biotechnology & Medical Research
Calendar :
2023-02-07 Earnings Release
Trading Rating :
Investor Rating :

Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 13
Last Close Price 50,35 $
Average target price 52,86 $
Spread / Average Target 4,99%